NL-OMON36481已完成不适用
ongitudinal analysis of tumor-specific T-cel immunity in irresectable stage IIIc and stage IV melanoma patients - Tumor-specific immunity in melanoma patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Histologically or cytologically proven irresectable stage IIIc or IV melanoma
- •-Age above 18 years
- •-WHO performance score 0, 1 or 2 at the time of study entry
- •-Written informed consent
排除标准
- •-Severe anemia (Hb < 6.0 mmol/L)
研究者
相似试验
已完成
不适用
Study of the Anti-tumoral Immune ResponseBreast CancerGliomaNCT02854644Centre Hospitalier Universitaire de Besancon167
已完成
不适用
Quantitative and qualitative analysis of T cells infiltrating the skin of children suffering from graft-versus-host diseasetransplantatieziekte (GvHD)GvHDGraft-versus-Host DiseaseNL-OMON37587niversitair Medisch Centrum Utrecht40
尚未招募
不适用
Post vaccination immunological response and immune monitoring for SARS-CoV-2CTRI/2021/08/035338Medanta Institute of Education and Research
尚未招募
不适用
ongitudinal analysis of lung cancer-specific immunity in stage III and IV non-small cell lung cancer patients10038666non-small cell lung cancerNL-OMON37300Antoni van Leeuwenhoek Ziekenhuis50
尚未招募
不适用
Analysis of tumor antigen expression and immune response using clinical samplesJPRN-UMIN000039445agasaki university100